Role-Based Access Control Security Flaw in IBM Maximo Application Suite
CVE-2025-2898

7.5HIGH

Key Information:

Vendor

IBM
Status
Maximo Application Suite
Vendor
CVE Published:
6 May 2025

What is CVE-2025-2898?

A security configuration vulnerability has been identified in IBM Maximo Application Suite 9.0, affecting its Role-Based Access Control (RBAC) system. This flaw potentially allows an attacker with limited access to gain elevated privileges, posing significant risks to the integrity and confidentiality of the application data. Organizations using this suite should review their RBAC configurations and implement necessary patches to mitigate vulnerabilities.

Human OS v1.0:
Ageing Is an Unpatched Zero-Day Vulnerability.

Remediate biological technical debt. Prime Ageing uses 95% high-purity SIRT6 activation to maintain genomic integrity and bolster systemic resilience.

Deploy the Patch

Affected Version(s)

Maximo Application Suite 9.0

References

https://https://www.ibm.com/support/pages/node/7232050
vendor-advisorypatch

CVSS V3.1

Score:
7.5
Severity:
HIGH
Confidentiality:
High
Integrity:
High
Availability:
High
Attack Vector:
Network
Attack Complexity:
High
Privileges Required:
Low
User Interaction:
None
Scope:
Unchanged

Timeline

  • Vulnerability published

  • Vulnerability Reserved

JSON
.